SCHEMBL19080169

SCHEMBL19080169

c1cc(-c2c3ccccc3c(-c3ccc4c(c3)oc3ccccc34)c3ccccc23)cc(-c2cc3ccccc3c3c2oc2c4ccccc4c4ccccc4c23)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.38
PRKDC P78527 1/20 0.36
PLA2G2A P14555 2/20 0.34
PLA2G4A P47712 2/20 0.34
PLA2G10 O15496 1/20 0.34
AHR P35869 2/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
KDM4E B2RXH2 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
GPR84 Q9NQS5 4/20 0.33
HCRTR1 O43613 1/20 0.33
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
DUSP3 P51452 1/20 0.32
RAB9A P51151 2/20 0.32
ABCG2 Q9UNQ0 2/20 0.32
HSD17B1 P14061 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080202 0.92 GPR84 (0.34) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL19080218 0.88 ALOX5 (0.35) ALOX5PRKDCAHRALDH1A1HPGD
SCHEMBL19080010 0.86 GPR84 (0.44) ALOX5PRKDCAHRALDH1A1HPGD
SCHEMBL24090016 0.85 AHR (0.41) ALOX5PRKDCPLA2G2APLA2G4AAHR
SCHEMBL19080170 0.85 AHR (0.35) ALOX5PRKDCPLA2G2APLA2G4APLA2G10
SCHEMBL19076325 0.84 PLA2G2A (0.36) ALOX5PLA2G2APLA2G4APLA2G10AHR
SCHEMBL19079980 0.83 ALDH1A1 (0.38) ALOX5AHRALDH1A1HPGDKDM4E
SCHEMBL19080122 0.83 GPR84 (0.42) ALOX5PRKDCALDH1A1HPGDKDM4E
SCHEMBL19080408 0.82 AHR (0.33) ALOX5PRKDCPLA2G2APLA2G4AAHR
SCHEMBL19076396 0.82 GPR84 (0.40) ALOX5PRKDCPLA2G2APLA2G4APLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885PRKDC 4792/4885PLA2G2A 4537/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885PRKDC 4792/4885PLA2G2A 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.